Myriad Genetics
MYGN
#7314
Rank
A$0.82 B
Marketcap
A$8.59
Share price
-5.88%
Change (1 day)
-13.87%
Change (1 year)

EPS for Myriad Genetics (MYGN)

EPS in 2023 (TTM): A-$4.56

According to Myriad Genetics's latest financial reports the company's current EPS (TTM) is A-$1.73. In 2022 the company made an earnings per share (EPS) of A-$2.02 a decrease over its 2021 EPS that were of A-$0.54.

EPS history for Myriad Genetics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$4.56126.31%
2022A-$2.02275.68%
2021A-$0.54-87.99%
2020A-$4.47755.56%
2019A-$0.52-194.74%
2018A$0.55-79.89%
2017A$2.74112.36%
2016A$1.29-35.97%
2015A$2.02-7.33%
2014A$2.18-37.24%
2013A$3.4759.33%
2012A$2.1820.97%
2011A$1.80-10.79%
2010A$2.0214.88%
2009A$1.7612.04%
2008A$1.57-454.1%
2007A-$0.44-42.45%
2006A-$0.77-8.62%
2005A-$0.84-18.88%
2004A-$1.0422.22%
2003A-$0.8525.81%
2002A-$0.67200%
2001A-$0.22-13.89%
2000A-$0.26-20.88%
1999A-$0.33-24.79%
1998A-$0.4461.33%
1997A-$0.27-34.21%
1996A-$0.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
A$3.92-327.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
A-$7.72 347.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.55-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
A-$73.85 4,177.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$12.09-800.00%๐Ÿ‡บ๐Ÿ‡ธ USA